Optimizing Therapeutic Antibody Function: Progress with Fc Domain Engineering

ISSN： 1173-8804

Source： BioDrugs, Vol.25, Iss.1, 2011-02, pp. : 1-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fc-Based Cytokines: Prospects for Engineering Superior Therapeutics

By Jazayeri Jalal A.

BioDrugs, Vol. 22, Iss. 1, 2008-01 ,pp. : 11-26

Adis International

Access to resources Recommend Favorite

Methodology for the Evaluation and Measurement of Therapeutic Progress

By Guillemot Didier

Therapie, Vol. 60, Iss. 4, 2005-01 ,pp. : 363-366

Adis International

Access to resources Recommend Favorite

Progress towards Therapeutic Application of RNA Interference for HIV Infection

By Singh Sunit K.

BioDrugs, Vol. 23, Iss. 5, 2009-10 ,pp. : 269-276

Adis International

Access to resources Recommend Favorite

Therapeutic and Prophylactic Potential of Small Interfering RNAs against Severe Acute Respiratory Syndrome: Progress to Date

By Chang Zhijie

BioDrugs, Vol. 21, Iss. 1, 2007-01 ,pp. : 9-15

Adis International

Access to resources Recommend Favorite

Tumor Necrosis Factor Receptor Pre-Ligand Assembly Domain is an Important Therapeutic Target in Inflammatory Arthritis

By Deng Guo-Min

BioDrugs, Vol. 21, Iss. 1, 2007-01 ,pp. : 23-29

Adis International

Access to resources Recommend Favorite